A detailed history of Fieldpoint Private Securities, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 124 shares of MRNA stock, worth $4,993. This represents 0.01% of its overall portfolio holdings.

Number of Shares
124
Previous 214 42.06%
Holding current value
$4,993
Previous $37,000 51.35%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$117.13 - $176.59 $10,541 - $15,893
-90 Reduced 42.06%
124 $18,000
Q1 2022

Apr 07, 2022

BUY
$126.46 - $235.05 $13,784 - $25,620
109 Added 103.81%
214 $37,000
Q4 2021

Jan 24, 2022

BUY
$225.82 - $368.51 $19,194 - $31,323
85 Added 425.0%
105 $27,000
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $3,328 - $7,267
15 Added 300.0%
20 $8,000
Q2 2021

Aug 12, 2021

BUY
$129.91 - $234.98 $649 - $1,174
5 New
5 $2,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Fieldpoint Private Securities, LLC Portfolio

Follow Fieldpoint Private Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.